Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Commentary

Managing nonspecific abdominal pain in children and young people

Neil Chanchlani, Thomas D. Walters and Richard K. Russell
CMAJ November 30, 2020 192 (48) E1639-E1640; DOI: https://doi.org/10.1503/cmaj.202555
Neil Chanchlani
Department of Paediatrics (Chanchlani), Royal Devon and Exeter Hospital, Exeter, UK; Department of Paediatric Gastroenterology (Walters), The Hospital for Sick Children, Toronto, Ont.; Department of Paediatric Gastroenterology (Russell), Royal Hospital for Sick Children, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas D. Walters
Department of Paediatrics (Chanchlani), Royal Devon and Exeter Hospital, Exeter, UK; Department of Paediatric Gastroenterology (Walters), The Hospital for Sick Children, Toronto, Ont.; Department of Paediatric Gastroenterology (Russell), Royal Hospital for Sick Children, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard K. Russell
Department of Paediatrics (Chanchlani), Royal Devon and Exeter Hospital, Exeter, UK; Department of Paediatric Gastroenterology (Walters), The Hospital for Sick Children, Toronto, Ont.; Department of Paediatric Gastroenterology (Russell), Royal Hospital for Sick Children, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading
KEY POINTS
  • Children present frequently to primary and emergency care with nonspecific abdominal pain.

  • Only a few treatment options exist to manage colicky, undifferentiated pain; however, most children will not present more than once or twice to health services for this problem.

  • Undifferentiated abdominal pain is poorly understood but likely multifactorial, arising from a combination of sensitizing medical events, psychosocial events and visceral hyperalgesia.

  • Among children who seek health care for this problem, 20%–25% go on to be diagnosed with a disorder of the brain–gut axis, “a functional gastrointestinal disorder,” for which international guidelines exist to guide management.

  • At first consultation, it is important to establish a positive therapeutic relationship between the clinician and the child and their parents, focusing on optimizing symptom control over unnecessary investigation and medicines.

In related research, Poonai and colleagues performed a randomized, blinded, double-dummy, single-centre trial to compare the efficacy of hyoscine butylbromide and acetaminophen in children and young people who presented to the emergency department with nonspecific, colicky abdominal pain.1 Nonspecific abdominal pain is common among children presenting to both primary and emergency care. In the absence of clear alarm features, other systemic features, objective evidence of poor growth or positive family history of a gastrointestinal disorder (e.g., inflammatory bowel disease, celiac disease, peptic ulcer disease), most patients can be managed safely in primary care without further bloodwork or imaging. Parents are usually advised to monitor symptoms and offer simple analgesia, such as acetaminophen and ibuprofen. Only 5% of children presenting to primary care will require referral to secondary care.2 However, establishing a positive relationship between the clinician and the child and their parent is important from the first presentation to lay the foundation for a potential future therapeutic relationship and complex interventions.

In their large trial, Poonai and colleagues observed a clinically significant reduction in pain scores among two-thirds of participants, all of whom received analgesia safely; however, hyoscine butylbromide was not found to be superior to acetaminophen.1 Although simple analgesia is known to be well-tolerated and safe in children, evidence regarding its efficacy in children with undifferentiated or chronic abdominal pain is lacking,3,4 so the related research adds usefully to the literature. However, 2 major study limitations warrant further consideration.

First, the trial enrolled only children aged 8–17 years who were screened between the hours of 1700 and 2300, thereby biasing participant selection by excluding preschool-age and early-school-age children and likely those whose pain developed during the school day. Children as young as 4 years commonly present with nonspecific abdominal pain. Younger children may have been excluded from the study owing to drug formulation or parental acceptability concerns. However, younger children’s pain is poorly understood, often overlooked by caregivers and possibly less responsive to analgesia, so the inclusion of younger children would have provided much-needed information. Abdominal pain that develops during the school day is more likely to have a functional cause, for which medication is less likely to be beneficial.5

Second, improvement in abdominal pain is multifactorial and usually not attributable to medical therapy alone.6,7 The ethics committee granting approval for the related research did not allow a placebo arm in the trial. However, the findings of several trials studying interventions for functional abdominal pain have suggested that a strong placebo effect may influence failure to show a significant effect of an intervention.8

Nevertheless, the findings of the related study are reassuring, as hyoscine butylbromide is already approved for use in children aged 6 years or older for smooth muscle spasm of the gastrointestinal and genitourinary tracts, including irritable bowel syndrome and bowel colic. Poonai and colleagues’ findings are novel for the pediatric population and consistent with those of a randomized controlled trial conducted among adults attending the emergency department, where acetaminophen was found to be as effective as hyoscine butylbromide, or a combination of the 2, in treating undifferentiated abdominal pain.9

Determining response to any analgesic requires reassessment of pain, but objective markers of improvement, such as whether the child is easily distracted and is able to eat, drink, or pass urine and stool, can be assessed during an observation period in hospital or in a follow-up telephone call to determine the next course of action. Parents’ views and assessment of progress should always be taken into account.

For children referred on to secondary care for further investigation of abdominal pain, there are few options other than simple analgesia for pain management. Since 2013, codeine is no longer approved for use in children younger than 12 years, and opioid-containing medicines can paradoxically worsen pain if it is related to constipation, as is much abdominal pain. Children who have already received simple analgesia may be offered an anticholinergic analgesic, such as hyoscine butylbromide, as a next step in the face of persistent pain.

Most children will present to health services only once or twice for nonspecific abdominal pain. However, 20%–25% will go on to be diagnosed with a disorder of the brain–gut axis, alternatively termed “functional gastrointestinal disorder,”10 such as functional dyspepsia, abdominal migraine, irritable bowel syndrome and functional abdominal pain not otherwise specified. The 2016 Rome IV criteria provide the latest diagnostic, investigative and management guidance for such disorders.11

While the pathophysiology underlying acute undifferentiated or chronic abdominal pain in children is incompletely understood, the pain likely arises from a combination of sensitizing medical events (e.g., bowel distention, inflammation or dysmotility), sensitizing psychosocial events (e.g., family stress, anxiety or a particular psychological coping style) and early-life events that lead to visceral hyperalgesia.11 Diagnosing a functional gastrointestinal disorder will usually take time — often months — during which patients are likely to experience a diminished quality of life.12,13 If symptoms are disruptive to the child’s school attendance or hobbies, use of analgesia may be beneficial, particularly if early use breaks a pain cycle, thus reducing the consequences of pain for the child. However, this potential benefit should be balanced against the possibility that habitual or reflexive medication use could become an unnecessary part of the solution.

The establishment of a positive therapeutic relationship between the clinician and the child and their parent is equally important to any medication use. Clear and careful explanation of brain–gut interactions by clinicians who see the child at initial presentation; reinforcement that investigations and medicines are usually unnecessary; and discussion of behavioural management options with a focus on optimising symptom coping skills,7,11 will build a foundation for this positive therapeutic relationship.

Footnotes

  • See the related research at www.cmaj.ca/lookup/doi/10.1503/cmaj.201055

  • Competing interests: Neil Chanchlani is funded by a research fellowship from Crohn’s and Colitis UK. Thomas Walters receives research support from Janssen Canada, Merck Canada and AbbVie Canada, and has consulted for Janssen Canada, Merck Canada, AbbVie Canada and Ferring. Richard Russell is supported by an NHS Research Scotland Senior Research Fellowship and has received speaker fees, travel support, and/or participated in medical board meetings with Nestlé, AbbVie, Dr. Falk Pharma, Takeda, Napp, Mead Johnson, Nutricia, and 4D Pharma.

  • This article was solicited and has not been peer reviewed.

  • Contributors: Neil Chanchlani and Richard Russell conceived the idea and drafted the manuscript. Thomas Walters provided critical advice and recommendations for revision. All authors approved the final version for publication and agree to be accountable for all aspects of the work.

  • Disclaimer: Neil Chanchlani is an associate editor for CMAJ and was not involved in the editorial decision-making process for this article.

References

  1. ↵
    1. Poonai N,
    2. Kumar K,
    3. Coriolano K,
    4. et al
    . Hyoscine butylbromide versus acetaminophen for nonspecific colicky abdominal pain in children: a randomized controlled trial. CMAJ 2020;192:E1612–9.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Gieteling MJ,
    2. Lisman-van Leeuwen Y,
    3. van der Wouden JC,
    4. et al
    . Childhood nonspecific abdominal pain in family practice: incidence, associated factors, and management. Ann Fam Med 2011;9:337–43.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Cooper TE,
    2. Fisher E,
    3. Anderson B,
    4. et al
    . Paracetamol (acetaminophen) for chronic non-cancer pain in children and adolescents. Cochrane Database Syst Rev 2017;8:CD012539.
    OpenUrl
  4. ↵
    1. Kanabar DJ
    . A clinical and safety review of paracetamol and ibuprofen in children. Inflammopharmacology 2017;25:1–9.
    OpenUrl
  5. ↵
    1. Assa A,
    2. Ish-Tov A,
    3. Rinawi F,
    4. et al
    . School attendance in children with functional abdominal pain and inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 2015;61:553–7.
    OpenUrl
  6. ↵
    1. Brusaferro A,
    2. Farinelli E,
    3. Zenzeri L,
    4. et al
    . The management of paediatric functional abdominal pain disorders: latest evidence. Paediatr Drugs 2018;20:235–47.
    OpenUrl
  7. ↵
    1. Chiou E,
    2. Nurko S
    . Management of functional abdominal pain and irritable bowel syndrome in children and adolescents. Expert Rev Gastroenterol Hepatol 2010;4:293–304.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Hoekman DR,
    2. Zeevenhooven J,
    3. van Etten-Jamaludin FS,
    4. et al
    . The placebo response in pediatric abdominal pain-related functional gastrointestinal disorders: a systematic review and meta-analysis. J Pediatr 2017;182:155–63.e7.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Remington-Hobbs J,
    2. Petts G,
    3. Harris T
    . Emergency department management of undifferentiated abdominal pain with hyoscine butylbromide and paracetamol: a randomised control trial. Emerg Med J 2012;29:989–94.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Scarpato E,
    2. Kolacek S,
    3. Jojkic-Pavkov D,
    4. et al.
    MEAP Group. Prevalence of functional gastrointestinal disorders in children and adolescents in the Mediterranean region of Europe. Clin Gastroenterol Hepatol 2018;16:870–6.
    OpenUrl
  11. ↵
    1. Hyams JS,
    2. Di Lorenzo C,
    3. Saps M,
    4. et al
    . Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology 2016;150:1456–68.e2.
    OpenUrlCrossRef
  12. ↵
    1. Robin SG,
    2. Keller C,
    3. Zwiener R,
    4. et al
    . Prevalence of pediatric functional gastrointestinal disorders utilizing the Rome IV criteria. J Pediatr 2018;195:134–9.
    OpenUrlPubMed
  13. ↵
    1. Varni JW,
    2. Bendo CB,
    3. Nurko S,
    4. et al.
    Pediatric Quality of Life Inventory (PedsQL) Gastrointestinal Symptoms Module Testing Study Consortium. Health-related quality of life in pediatric patients with functional and organic gastrointestinal diseases. J Pediatr 2015;166:85–90.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 192 (48)
CMAJ
Vol. 192, Issue 48
30 Nov 2020
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Managing nonspecific abdominal pain in children and young people
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Managing nonspecific abdominal pain in children and young people
Neil Chanchlani, Thomas D. Walters, Richard K. Russell
CMAJ Nov 2020, 192 (48) E1639-E1640; DOI: 10.1503/cmaj.202555

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Managing nonspecific abdominal pain in children and young people
Neil Chanchlani, Thomas D. Walters, Richard K. Russell
CMAJ Nov 2020, 192 (48) E1639-E1640; DOI: 10.1503/cmaj.202555
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • Hyoscine butylbromide versus acetaminophen for nonspecific colicky abdominal pain in children: a randomized controlled trial
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Time for a regulatory framework for pediatric medications in Canada
  • Optimizing timing of completion of the Surgical Safety Checklist to account for emergence from anesthesia
  • Shifting from cytology to HPV testing for cervical cancer screening in Canada
Show more Commentary

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire